David R. Wells, Chief Financial Officer at ENDRA Life Sciences Inc. (NDRA), bought 10,000 shares at $1.56 ($16K) on 2019-08-22, disclosed to the SEC on 2019-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.56 | 5,000 | $8K | 50.2% |
| 2 | $1.55 | 5,000 | $8K | 49.8% |
| Total | $1.55 avg | 10,000 | $16K | 100% |
| Filing → |
| SINX | BUY | 2011-01-03 | $1K | — | Filing → |
| SINX | BUY | 2010-12-15 | $1K | — | Filing → |
| SINX | BUY | 2010-12-10 | $1K | — | Filing → |